πŸ‡ΊπŸ‡Έ FDA
Patent

US 10251881

Particulate materials

granted A61KA61K31/4985A61K47/06

Quick answer

US patent 10251881 (Particulate materials) held by Nektar Therapeutics expires Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Nektar Therapeutics
Grant date
Tue Apr 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 04 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61K, A61K31/4985, A61K47/06, A61K47/08, A61K9/008